Member Info for GloriaMarket

4.45p paid. FOMO (fear of missing out) is strong with this stock.

This increase in sp is not based on nonsense, as all previous GDR spikes were based on. The help from FDA through the breakthrough device program and the expected full recommendation by NICE for the stroke related test AFTER the recent placement heralds a turning point in GDR's fortunes. This is the reason Peel Hunt helped GDR get over the line with wrt to that placement and the last round of funding. They enable GDR to escape the death spiral deal with RF. Sure Peel Hunt are selling but they obvsiously knew the risks were minimal that their recent 20% holding would still turn a profit for them. In short they believe in GDR and its products. Tbh it would be great news if they have stopped selling and want to maintain say a 5% interest in GDR. The lack of RNSs from them recently suggests to me this may signal that they are in no rush to dump the whole 20%. Of course I could be completely wrong. Either way Peel Hunt believe in GDR.

Peel hunt have yet to sell out. I suspect either Mr stephen11 or peel hunt are still derisking their unwanted exposure.

"Whoever mentioned Warren Buffet. He wasn't talking about AIM"

indeed, care to jump in again Mr Shivest?

Initial trades are high!

Hardly surprising when gdr have already diluted to fund the coming year and a it more, FDA has announced its cooperation in fasttracking AIH,, an announcement by NICE regarding Full Approval of stroke marker and as mr lionel1 spotted a trust is holding an introduction to the usage of the strokemarker to its staff.

"Can we all have a 1 minutes silence for poor Shivest who sold this morning for 3.66 then spent most the day deramping..."

Lol. Not very often that gdr embitters short term holders!

" Workshops scheduled over next few months about CYP2C19 and Clopidogrel ..

https://engage360.tractivity.co.uk/0d0e0970-2c3b-47a9-9801-7c0e57d81681/events/5?q=2022%7cDNUxoAysXHjDjX0zRcEsff1JRLwFU3DJu9ehN7ugEZntg62WUI6m0Qvo8hhNte17 "

I agree with muminr, an incredible find Mr Lionel1

US investors are awake.

"I bet everyone here would sell the lot if offered £1 a share."

No, there will be some still waiting to get their money back , even at that price.

"Gloria are u invested in GDR?"

Yes. Are you?

"Loving the Day Trader Ramping $hyte on here today lol, they will spout absolutely ANYTHING to get they're trade. lolol"

Nasa are interested in AIHL poc test as part of their mission to mars.

Thanks Mr Luke.

Your article also states the effect on adults. GDR has focussed on a gene test for babies but surely adults who possess this gene are at risk of a degree of hearing loss? Your article states...

"Anywhere from 20 to 60 percent of adults who are given aminoglycosides experience some degree of hearing loss, from mild to profound. It usually causes high-frequency hearing loss. At higher doses given over longer period of times, it may affect other ranges of hearing, such as low frequencies, and eventually cause complete deafness."

If this is the case, then the patients that will be tested by the POC kit will include adults surely? US medical companies will want to protect themselves from losing legal cases of negligence. this is pure ramping , as I don't think GDR has mentioned that their AIHL product can help prevent hearing degradation in adults too. Perhaps GDR has simply not considered testing against adults, as only infants can sucumb to complete deafness?

"Tree shake well and truly over!"

Yes, mr Shivest did your sell order unexpectedly get hit this morning and you bought in again on the dip?

Lol Mr Davey and Mr Gordon.... I thought GDR had enough bikkering couples but I guess there is always room for more..

"Cost of one test to prevent hearing loss in a baby in UK was circa £130 .

So annual income in US - 168 dollars multiplied by 480,000. 168 dollars multiplied by 480,000."

How did you find 480 000 exactly?

US investors will now be speculating on whether GDR will become a relative unicorn (obviously not in the same league as tech giants but with a very low market cap, as it still is now and the huge cash cow potential of AIHL in US. As well as the strokemarker approval. The only thing that is holding me back is that Mr Cheek is not truly invested himself. But perhaps that could change soon. If an RNS was released to say Mr Cheek bought shares this week, then I'd be very happy to hold.

The FDA are now on GDR's side. This is incredible news. I wonder what happened to other companies whose product joined the breakthrough programme.

This news wasn't expected so soon. imo this is the best RNS GDR have ever had. The RNS and the breakthrough programme tells investors that the FDA are now doing their best to help our product get to market as soon as possible, the very lucrative US market . All UK related RNS's pale into insignficance compared to this RNS imo, simply because of the size of the US market and the litigation costs in USA. Every health company that uses the anitbiotic gentamicin will want this. And don't forget , the side effects of this antibiotic on the ear affect 11% of the people who take it, not just babies.... /

granted AIHL won't prevent hearing loss, as the effects are not all down to a the person carrying the specific gene AIHL tests for, but unless I'm wrong it means that EVERY US PATIENT who will receive gentamicin must first be tested for the gene in order to reduce the chance of damage to the ear (if there is damage and the medical centre didn't use AIHL poc to test beforehand, they will be sued).

"Inner ear

About 11% of the population who receives aminoglycosides experience damage to their inner ear.[21] The common symptoms of inner ear damage include tinnitus, hearing loss, vertigo, trouble with coordination, and dizziness.[22] Chronic use of gentamicin can affect two areas of the ears. First, damage of the inner ear hair cells can result in irreversible hearing loss. Second, damage to the inner ear vestibular apparatus can lead to balance problems.[22] To reduce the risk of ototoxicity during treatment, it is recommended to stay hydrated.[13]

Factors that increase the risk of inner ear damage include:[13][14]

Increased age

High blood uric acid levels

Kidney dysfunction

Liver dysfunction

Higher doses

Long courses of therapy

Also taking strong diuretics (e.g., furosemide)"

Hello Mr Stockpick.

I bought when the last RNS regarding the delay gave me an excellent opportunity and the price fell back to approx 1.6-1.7p.

long term sceptic, yes and rightly so imo. I'm fortunate my patience paid off . Certainly not grumbling that I didn't commit when it was 1.5p (or less since at the time Peel Hunts intentions were not clear at all).

Fingers crossed GLA.